Delaware Business Court Insider | News
By Ellen Bardash | November 19, 2021
The shareholders suit said Emergent was in no position to produce millions of doses of the Johnson & Johnson and AstraZeneca COVID-19 vaccines.
Delaware Business Court Insider
By Ellen Bardash | November 19, 2021
U.S. District Judge Colm F. Connolly issued an order Friday afternoon staying the case until 14 days after the resolution of those filed by Xiulu Ruan and Shakeel Kahn, which the high court agreed to hear earlier this month.
Delaware Business Court Insider | News
By Ellen Bardash | November 18, 2021
The summary decision came more than two years after shareholders of the acquired company FerroKin Biosciences Inc. proved they were entitled to a missed clinical trial milestone payment.
By Alaina Lancaster | Zack Needles | November 12, 2021
In this week's episode, Morgan Lewis partners Collie James and Wendy West Feinstein discuss the significance of the first trial win for drug companies facing nationwide litigation over their roles in the opioid crisis, as well as the benefits of virtual litigating.
Delaware Business Court Insider | News
By Ellen Bardash | November 4, 2021
The decision turned on the court's finding that a device is inextricably tied to the intellectual property behind it when it comes to patent disputes.
Delaware Business Court Insider
By Ellen Bardash | October 19, 2021
The Justice Department said a pharma company's argument focused on the wording of a federal program ignored the intent behind it: to give certain entities discounted drug prices.
Delaware Business Court Insider | News
By Ellen Bardash | September 10, 2021
Since the injunction isn't being granted, Glasscock said there's no reason to expedite the rest of the case, which centers on a contractual dispute between the two drug companies.
Delaware Business Court Insider
By Ross Todd | August 27, 2021
Following a seven-day remote bench trial last year, Christopher Sipes, Erica Andersen, and Brianne Bharkhda of Covington & Burling got a ruling from a federal judge in Delaware this week finding the four patents covering cancer treatment Imbruvica were valid and infringed.
Delaware Business Court Insider | News
By Ellen Bardash | August 3, 2021
An order requiring a pharmaceutical company to pay $1.7 million of its foes' legal fees is the first to hold a corporate defendant financially liable for the cost of Section 220 litigation. Lawyers are wondering if the ruling could be applied in other types of corporate litigation.
Delaware Business Court Insider | News
By Ellen Bardash | July 23, 2021
McCormick's six-page opinion repeatedly blasted Gilead Sciences and its counsel as crossing over the line of aggressive litigation, and starts off with a reference to the court's right to shift fees to deter abusive tactics.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS